GR3035287T3 - Insulin and amylin containing composition for the treatment of insulin deficient mammals. - Google Patents
Insulin and amylin containing composition for the treatment of insulin deficient mammals.Info
- Publication number
- GR3035287T3 GR3035287T3 GR20010400101T GR20010400101T GR3035287T3 GR 3035287 T3 GR3035287 T3 GR 3035287T3 GR 20010400101 T GR20010400101 T GR 20010400101T GR 20010400101 T GR20010400101 T GR 20010400101T GR 3035287 T3 GR3035287 T3 GR 3035287T3
- Authority
- GR
- Greece
- Prior art keywords
- insulin
- amylin
- treatment
- containing composition
- deficient mammals
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 6
- 102000004877 Insulin Human genes 0.000 title abstract 3
- 108090001061 Insulin Proteins 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 3
- 229940125396 insulin Drugs 0.000 title abstract 3
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 title abstract 2
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002950 deficient Effects 0.000 title 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 229920002527 Glycogen Polymers 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 229940096919 glycogen Drugs 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 238000010348 incorporation Methods 0.000 abstract 2
- 210000002027 skeletal muscle Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70499591A | 1991-05-24 | 1991-05-24 | |
| PCT/US1992/004351 WO1992020366A1 (en) | 1991-05-24 | 1992-05-23 | Insulin and amylin containing composition for the treatment of insulin deficient mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3035287T3 true GR3035287T3 (en) | 2001-04-30 |
Family
ID=24831674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010400101T GR3035287T3 (en) | 1991-05-24 | 2001-01-24 | Insulin and amylin containing composition for the treatment of insulin deficient mammals. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0586592B1 (el) |
| JP (1) | JPH06510753A (el) |
| AT (1) | ATE197764T1 (el) |
| AU (2) | AU2169392A (el) |
| CA (1) | CA2109604A1 (el) |
| DE (1) | DE69231583T2 (el) |
| DK (1) | DK0586592T3 (el) |
| ES (1) | ES2153828T3 (el) |
| GR (1) | GR3035287T3 (el) |
| SG (1) | SG44838A1 (el) |
| WO (1) | WO1992020366A1 (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656590A (en) * | 1991-05-24 | 1997-08-12 | Amylin Pharmaceuticals, Inc. | Treatment of anorexia and related states |
| WO2001000223A2 (en) * | 1999-06-25 | 2001-01-04 | Minimed Inc. | Multiple agent diabetes therapy |
| AU2002248464A1 (en) | 2001-02-21 | 2002-09-12 | Medtronic Minimed, Inc. | Stabilized insulin formulations |
| US6737401B2 (en) | 2001-06-28 | 2004-05-18 | Metronic Minimed, Inc. | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
| GB8915712D0 (en) * | 1989-07-08 | 1989-08-31 | Macintyre Iain | Medical treatment |
-
1992
- 1992-05-23 AU AU21693/92A patent/AU2169392A/en not_active Abandoned
- 1992-05-23 WO PCT/US1992/004351 patent/WO1992020366A1/en not_active Ceased
- 1992-05-23 DK DK92913644T patent/DK0586592T3/da active
- 1992-05-23 DE DE69231583T patent/DE69231583T2/de not_active Expired - Lifetime
- 1992-05-23 AT AT92913644T patent/ATE197764T1/de active
- 1992-05-23 SG SG1996008450A patent/SG44838A1/en unknown
- 1992-05-23 ES ES92913644T patent/ES2153828T3/es not_active Expired - Lifetime
- 1992-05-23 CA CA002109604A patent/CA2109604A1/en not_active Abandoned
- 1992-05-23 EP EP92913644A patent/EP0586592B1/en not_active Expired - Lifetime
- 1992-05-23 JP JP5500328A patent/JPH06510753A/ja active Pending
-
1996
- 1996-08-07 AU AU61964/96A patent/AU6196496A/en not_active Abandoned
-
2001
- 2001-01-24 GR GR20010400101T patent/GR3035287T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0586592T3 (da) | 2000-12-27 |
| JPH06510753A (ja) | 1994-12-01 |
| AU6196496A (en) | 1996-10-10 |
| DE69231583T2 (de) | 2001-03-29 |
| ES2153828T3 (es) | 2001-03-16 |
| CA2109604A1 (en) | 1992-11-26 |
| DE69231583D1 (de) | 2001-01-04 |
| WO1992020366A1 (en) | 1992-11-26 |
| EP0586592A1 (en) | 1994-03-16 |
| AU2169392A (en) | 1992-12-30 |
| SG44838A1 (en) | 1997-12-19 |
| EP0586592B1 (en) | 2000-11-29 |
| ATE197764T1 (de) | 2000-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2017471B3 (es) | Aposito para el tratamiento de heridas y procedimiento de preparacion. | |
| GEP19981274B (en) | Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition | |
| KR960014776B1 (en) | Composition for stimulating hair growth | |
| ZA858105B (en) | A pharmaceutical composition and a method of treating the body | |
| LTIP1582A (en) | Compositions of medicinal preparation and hyaluronic acid for treatment of conditions and disease | |
| IN166787B (el) | ||
| GB9517443D0 (en) | Increasing creatine and glycogen concentration in muscle | |
| HK16492A (en) | Pharmaceutical compositions of somatostatin analogues | |
| GR1002802B (el) | Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος | |
| GR3031129T3 (en) | Enhancement of glutathione levels with glutamine | |
| BG104135A (en) | Diabetes treatment with thiazolydindion, a form increasing the insulin and biguanide secretion | |
| EP1952819A3 (en) | Method for preventing gastritis using amylin or amylin agonists | |
| GR860900B (en) | Amino-propanol derivatives method for their preparation their use and medicaments containing them | |
| GR3025792T3 (en) | Use of phosphonates for the treatment of osteoporosis. | |
| ES2002083A6 (es) | Un metodo para preparar derivados de piroglutamida | |
| IL103383A0 (en) | Pharmaceutical compositions containing glutamine and methods for the use thereof | |
| NO885023D0 (no) | Fremgangsmte for reduksjon av nitrogenoxydinnholdet i en avlsstr under anvendelse av sukker. | |
| SG44838A1 (en) | Insulin and amylin containing composition for the treatment of insulin deficient mammals | |
| IL86928A (en) | Castanospermine esters and glycosides,their preparation and compositions containing them for treating diabetes and postprandial hyperglycemia | |
| EP0285441A3 (en) | Synergistic immunostimulating composition and method | |
| ZA871654B (en) | Method and compositions for increasing mammary parenchyma | |
| GR3022074T3 (en) | Method for treatment or prevention of obesity. | |
| PT85950A (en) | Process for the preparation of protamine zinc insulin compositions useful for treating diabetes | |
| CA2010054A1 (en) | Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin | |
| GR1002317B (el) | Προαγωγη της αναπτυξεως χοιρων. |